Boston cancer centers certified for gene-altering lymphoma therapy – MassLive.com
MassLive.com |
Boston cancer centers certified for gene-altering lymphoma therapy
MassLive.com The approval of Kite Pharma's Yescarta (axicabtagene ciloleucel) for CAR T-cell therapy for adults with some forms of relapsed non-Hodgkin lymphoma makes it the second gene therapy to become available in the United States. In August, the FDA approved … |
